Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Invested Capital (2024 - 2025)

Historic Return on Invested Capital for Iovance Biotherapeutics (IOVA) over the last 3 years, with Q3 2025 value amounting to 0.59%.

  • Iovance Biotherapeutics' Return on Invested Capital fell 400.0% to 0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.61% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Iovance Biotherapeutics' Return on Invested Capital is 0.59%, which was down 400.0% from 0.56% recorded in Q2 2025.
  • Over the past 5 years, Iovance Biotherapeutics' Return on Invested Capital peaked at 0.53% during Q4 2024, and registered a low of 0.73% during Q1 2024.
  • In the last 3 years, Iovance Biotherapeutics' Return on Invested Capital had a median value of 0.58% in 2025 and averaged 0.61%.
  • As far as peak fluctuations go, Iovance Biotherapeutics' Return on Invested Capital surged by 2000bps in 2024, and later plummeted by -400bps in 2025.
  • Over the past 3 years, Iovance Biotherapeutics' Return on Invested Capital (Quarter) stood at 0.73% in 2023, then grew by 27bps to 0.53% in 2024, then decreased by -12bps to 0.59% in 2025.
  • Its Return on Invested Capital stands at 0.59% for Q3 2025, versus 0.56% for Q2 2025 and 0.53% for Q1 2025.